TCL Archive Letrozole Combination Increases PFS In ER+ and HER2-Negative Breast Cancer January 25, 2013
TCL Archive ODAC votes 9-6 in favor of Clolar for pediatric acute lymphoblastic leukemia, but votes against Marqibo for non-Hodgkin’s lymphoma. December 10, 2004
TCL Archive Also HHS Inspector General is reviewing Lester Crawford’s departure from FDA. October 28, 2005
